» Download Public Reports
22 reports
- Company report
- December 2011
- 4 pages
... Optimism relating to our vitamin d activities and a leading antibody known as vitd3.5H10. This has now moved into large scale manufacturing at the company in order to supply quantities of antibody required ...
June 2011
... Companies who work in the area of biosimilars and offer an opportunity to learn about the latest developments and technological advancements in the industry. If you would like to host a spotlight presentation ...
January 2011
... In vaccines stimulate the immune system to produce specific antibodies as though it had been exposed to a natural infection This presents no risk to the person receiving the vaccine Immunity develops ...
October 2010
... Be difficult to 73 define an appropriate equivalence margin for pharmacodynamic equivalence based on clinical 74 relevance, and to provide reassurance that all relevant aspects of a biosimilar mab as regards ...
October 2011
... European mab biosimilar guideline overcome the unique manufacturing challenges facing the development of novel therapies such as bi-specifics, antibody fragments, combination antibodies and adcs find novel ...
October 2011
... Such as mrsa (drug resistant staphylococcus bacteria), other serious bacterial infections, and influenza. Contrafect S scientific approach is based on the following principles: o monoclonal antibodies ...
June 2012
... Agreements for clinical trials to proceed and eventually release onto the market. An overview of the structural characterisation requirements for monoclonal antibodies will be delivered. Biography following ...
April 2012
... An Organism (Virus, bacterium, fungus, yeast, insect, cultured cells, transgenic animals and plants - any living thing that can be manipulated) used to produce a product of interest (a protein/enzyme ...
December 2012
... Eurostars tsb national- sbri, ktp, biomedical catalyst devolved administration/regional funding- manufacturing advisor service (mas) t e c h n o lo g y r e a d in e s s l e v e l (t r l ) t e c h n o lo g ...